Showing 11,001 - 11,020 results of 102,485 for search '(( 50 ((teer decrease) OR (mean decrease)) ) OR ( 5 ((wt decrease) OR (a decrease)) ))', query time: 1.79s Refine Results
  1. 11001
  2. 11002

    Fig 5 - by Raghu Arghal (20598093)

    Published 2025
    “…<p>Fig 5a shows the increase in the death counts of the static vaccination policy over that of the optimal policy as a percentage of the latter. …”
  3. 11003

    Pre-administration of metformin 3 days before irradiation significantly decreases the number of micronuclei in murine bone marrow cells and the number of DNA damage foci in colon a... by Silvia Siteni (10344070)

    Published 2024
    “…<p>(A) Metformin 200 mg/kg pre-administration significantly decreases the number of micronuclei in mice bone marrow cells, compared to the 7.5 cGy control, in 129/sv mice one-way ANOVA, **p<0.01, ****p<0.0001). …”
  4. 11004

    Scleral morphological changes in P84 APC<sup>min</sup> mice and age-matched normal WT littermates. by Zhen Liu (74646)

    Published 2015
    “…<p>TEM compares collagen fibril morphology in cross-section from the posterior sclera of wild type (A) and APC<sup>Min</sup> mice (B). A, WT fibrils have a regular, cylindrical contour whereas APC<sup>Min</sup> mice sclera is more irregular and disorganized. …”
  5. 11005

    DataSheet_1_m6A Methyltransferase METTL3 Promotes the Progression of Primary Acral Melanoma via Mediating TXNDC5 Methylation.pdf by Zhanghui Yue (11957456)

    Published 2022
    “…Knockdown of METTL3 decreased global m<sup>6</sup>A level in melanoma cells. …”
  6. 11006
  7. 11007

    Structure–Activity Studies of 1<i>H</i>‑Imidazo[4,5‑<i>c</i>]quinolin-4-amine Derivatives as A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulators by Lucas B. Fallot (14106171)

    Published 2022
    “…We previously reported 1<i>H</i>-imidazo[4,5-<i>c</i>]quinolin-4-amines as A<sub>3</sub> adenosine receptor (A<sub>3</sub>AR) positive allosteric modulators (PAMs). …”
  8. 11008

    Structure–Activity Studies of 1<i>H</i>‑Imidazo[4,5‑<i>c</i>]quinolin-4-amine Derivatives as A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulators by Lucas B. Fallot (14106171)

    Published 2022
    “…We previously reported 1<i>H</i>-imidazo[4,5-<i>c</i>]quinolin-4-amines as A<sub>3</sub> adenosine receptor (A<sub>3</sub>AR) positive allosteric modulators (PAMs). …”
  9. 11009
  10. 11010

    S5 Fig - by Pablo Capilla-Lasheras (5209658)

    Published 2024
    “…To do this, we estimated the signal strength (RSSI)-distance relationship within our study site (panel A) using biologically realistic locations for the birds via the method described below, and then calculated the mean signal strength obtained at 50 m distance from a receiver in this context for use as this threshold value (as the mean ± SE distance between neighbouring territory centres is just 93.7 m ± 4.56 m in our study population). …”
  11. 11011
  12. 11012
  13. 11013
  14. 11014

    Fig 5 - by Kevin Tsai (197484)

    Published 2024
    “…Case 1 represents the scenario where the scaling factor <i>n</i> starts with 5 and increase to 12 in 5×10<sup>3</sup> simulation time steps, and then decrease to 7 in 5×10<sup>3</sup> simulation time steps. …”
  15. 11015

    Effects of T5-1 and T5-12 on TAS2R5 expression during protein synthesis inhibition. by Donghwa Kim (252081)

    Published 2025
    “…In the presence of CHX, T5-1 caused a decrease in receptor expression with the prolonged exposure, while T5-12 exposure had no significant effect on expression. * , P < 0.01 vs vehicle control.…”
  16. 11016

    Recruitment flow diagram of the current study. by Somayeh Momenyan (10111603)

    Published 2025
    “…White ethnicity, higher somatic symptom, pain catastrophizing, and use of medication pre-injury were associated with lower pre-injury EQ-5D-5L summary and EQ-VAS scores. Phase 1 EQ-5D-5L decreases were associated with female sex, no pre-existing body complaints, lack of expectation for a fast recovery, higher ISS, higher injury pain, and neck, spine/back, upper extremity, or lower extremity injuries. …”
  17. 11017
  18. 11018
  19. 11019
  20. 11020